User:Tereza Čalounová/Sandbox 1
From Proteopedia
m |
|||
Line 41: | Line 41: | ||
[[Image:CardiolipinSynthesis.jpg|thumb|Cardiolipin synthesis. <ref name="cit16"> Rochellehx. File:Eukaryotic pathway.jpg. In: Wikimedia Commons [online]. 23. 4. 2009 [cit. 2019-04-27]. Available at: https://commons.wikimedia.org/wiki/File:Eukaryotic_pathway.jpg</ref>]] | [[Image:CardiolipinSynthesis.jpg|thumb|Cardiolipin synthesis. <ref name="cit16"> Rochellehx. File:Eukaryotic pathway.jpg. In: Wikimedia Commons [online]. 23. 4. 2009 [cit. 2019-04-27]. Available at: https://commons.wikimedia.org/wiki/File:Eukaryotic_pathway.jpg</ref>]] | ||
- | The first step in the cardiolipin synthesis is a conversion of cytidine diphosphate diacylglycerol to phosphatidylglycerol phosphate by the enzyme phosphatidylglycerol phosphate (PGP) synthase. Followed by dephosphorylation by PGP phosphatase to phosphatidylglycerol. Lastly phosphatidylglycerol is converted to cardiolipin in condensation reaction catalyzed by cardiolipin synthase. <ref name="cit15"> | + | The first step in the cardiolipin synthesis is a conversion of cytidine diphosphate diacylglycerol to phosphatidylglycerol phosphate by the enzyme phosphatidylglycerol phosphate (PGP) synthase. Followed by dephosphorylation by PGP phosphatase to phosphatidylglycerol. Lastly phosphatidylglycerol is converted to cardiolipin in condensation reaction catalyzed by cardiolipin synthase. <ref name="cit15">PMID: 24445246</ref> |
The efficiency of these synthesis depends on the amount of phosphatidyl glycerol in the mitochondrial membrane. The lesser amount the bigger effectiveness. <ref name="cit13" /> | The efficiency of these synthesis depends on the amount of phosphatidyl glycerol in the mitochondrial membrane. The lesser amount the bigger effectiveness. <ref name="cit13" /> | ||
Revision as of 21:14, 27 April 2019
This is our page where we will share informations about protein Tafazzin as a part of a school project with my classmates. This page is under a construction so please be aware of it. Zde přidám úvod
Tafazzin
Theoretical Model: The protein structure described on this page was determined theoretically, and hence should be interpreted with caution. |
Tafazzin is a protein located in mitochondrial inner membranes. It is involved in altering cardiolipin. Cardiolipin is key in maintaining mitochondrial shape, energy production, and protein transport within cells. The full-length tafazzin protein contains 292 amino acids and has a molecular weight of 33459 daltons. Mutations in gene associated with this protein can cause Barth Syndrome. Barth syndrome (BTHS),is a genetic disorder diagnosed almost exclusively in males. BTHS is rare, it is estimated to affect 1 in 300,000 to 400,000 individuals worldwide. Males with BTHS have weak heart and skeletal muscles which can lead to heart failure. Another of the symptoms is neutropenia which can lead to infections. [1]
|
References
- ↑ Barth syndrome. In: Ghr.nlm.nih.gov [online]. Rockville Pike: U.S. National Library of Medicine, 2019 [cit. 2019-04-27]. Available at: https://ghr.nlm.nih.gov/condition/barth-syndrome#
- ↑ 2.0 2.1 2.2 2.3 Q16635 (TAZ_HUMAN). In: Https://www.uniprot.org/ [online]. Cambridge, Geneva, Washington: UniProt, 2019 [cit. 2019-04-27]. Available at: https://www.uniprot.org/uniprot/Q16635?fbclid=IwAR3v10lUTRZfb0NFOYKC4wjaherdU9PIVJ8T63jkC9RfNu_5OQ2IpoDR0iY
- ↑ 3.0 3.1 3.2 3.3 CHRISTIE, William. Cardiolipin (Diphosphatidylglycerol). In: Www.lipidhome.co.uk [online]. Hutton: The LipidWeb, 2019 [cit. 2019-04-27]. Available at: http://www.lipidhome.co.uk/lipids/complex/dpg/index.htm
- ↑ 4.0 4.1 4.2 4.3 Houtkooper, R. H., & Vaz, F. M. (2008). Cardiolipin, the heart of mitochondrial metabolism. Cellular and Molecular Life Sciences, 65(16), 2493–2506. doi:10.1007/s00018-008-8030-5
- ↑ Cardiolipin structure. In: Commons.wikimedia.org [online]. San Francisco: Wikimedia, 2019 [cit. 2019-04-27]. Available at: https://commons.wikimedia.org/wiki/File:Cardiolipin_structure.svg?uselang=cs
- ↑ Rochellehx. File:Eukaryotic pathway.jpg. In: Wikimedia Commons [online]. 23. 4. 2009 [cit. 2019-04-27]. Available at: https://commons.wikimedia.org/wiki/File:Eukaryotic_pathway.jpg
- ↑ 7.0 7.1 7.2 Raja V, Greenberg ML. The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotype. Chem Phys Lipids. 2014 Apr;179:49-56. doi: 10.1016/j.chemphyslip.2013.12.009., Epub 2014 Jan 17. PMID:24445246 doi:http://dx.doi.org/10.1016/j.chemphyslip.2013.12.009
- ↑ TAZ gene. In: Www.ncbi.nlm.nih.gov [online]. Rockville Pike: U.S. National Library of Medicine, 2014 [cit. 2019-04-27]. Available at: https://ghr.nlm.nih.gov/gene/TAZ#
- ↑ 9.0 9.1 Hijikata A, Yura K, Ohara O, Go M. Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain. Meta Gene. 2015 Apr 22;4:92-106. doi: 10.1016/j.mgene.2015.04.001. eCollection, 2015 Jun. PMID:25941633 doi:http://dx.doi.org/10.1016/j.mgene.2015.04.001
- ↑ 10.0 10.1 https://ghr.nlm.nih.gov/condition/barth-syndrome#
- ↑ 11.0 11.1 https://www.sciencedirect.com/science/article/pii/S092544391830334X?via%3Dihub
- ↑ 12.0 12.1 https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/pd.2599
- ↑ https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/tafazzin
- ↑ 14.0 14.1 14.2 14.3 https://www.ncbi.nlm.nih.gov/books/NBK247162/
- ↑ 15.0 15.1 https://swissmodel.expasy.org/repository/uniprot/Q16635
- ↑ http://pfam.xfam.org/protein/Q16635
- ↑ https://pfam.xfam.org/family/PF01553#tabview=tab4
- ↑ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC107040/